BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Push to Public Continues as Biotech Dominates the IPO List This Week

  Biotech companies are dominating Nasdaq’s IPO scheduled this week. Here’s who is making their big public debut.

  June 17, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  BioMidwest

  Tumors Next Target for T Cell Therapies with U Minnesota Research

  New research shows T cells can be engineered to migrate more effectively inside tumor microenvironments, raising hopes of reproducing the remarkable outcomes seen for certain hematological cancer patient subsets in broader populations and indications.

  June 17, 2021

   · 

  4 min read

   · 

  Mark Zipkin
• 

  Policy

  Recent Studies, Reports Call for Further Probe Into COVID-19 Origins

  Scientists call for more investigation into the origin of the virus, particularly in China, but China now wants to include the U.S. in the probe.

  June 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  BioSpace Movers & Shakers, June 18

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  June 17, 2021

   · 

  9 min read

   · 

  Alex Keown
• 

  Genetown

  Research Roundup: “Bad Fat” Slows Killer T-Cells from Attacking Cancer and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  June 17, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  CureVac Out of the COVID Race? Vaccine Only 47% Effective

  The new findings likely throw a wrench in the company’s plans to deliver millions of much-needed vaccine doses to the European Union soon.

  June 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  Xilio Rides First Half Momentum to IND Acceptance for Checkpoint Inhibitor

  XTX101 is a tumor-selective anti-CTLA-4 monoclonal antibody designed to improve upon the safety of current therapies in the same class.

  June 17, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Inside ReCode’s New-in-Class Approach to Treating Cystic Fibrosis

  The data showed that both experimental therapies restored function in the cystic fibrosis transmembrane conductance regulator gene.

  June 17, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Career Advice

  9 Best Remote Companies to Work for in 2021 [+ Best Remote Work Tools]

  Here are some of the best remote companies to work for this year. These companies can provide you with the right kind of exposure that will help you professionally.

  June 17, 2021

   · 

  7 min read

   · 

  Lorenzo Soliman
• 

  Drug Development

  Novartis Scores Breakthrough Therapy Designation to Speed Prostate Cancer Drug Approval

  The FDA granted it to Lu-PSMA-617, an investigational radioligand therapy to treat metastatic castration-resistant prostate cancer.

  June 17, 2021

   · 

  2 min read

   · 

  Alex Keown